| General Information of Drug Metabolite (DM) (ID: DM018097) |
| DM Name |
Elvitegravir Metabolite M4
|
| Structure |
|
|
3D MOL is unavailable
|
2D MOL is unavailable
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
UDP-glucuronosyltransferase 1A1 (UGT1A1)
|
DME0004
|
| Conjugation - Glucuronidation |
Elvitegravir
|
[1] |
|
UDP-glucuronosyltransferase 1A3 (UGT1A3)
|
DME0041
|
| Conjugation - Glucuronidation |
Elvitegravir
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| Elvitegravir |
DR0570
|
Approved |
Human immunodeficiency virus infection |
|
|
| References |
| 1 |
In vitro resistance selections using elvitegravir, raltegravir, and two metabolites of elvitegravir M1 and M4
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
